UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 345

Sortiert nach

Associations of Delay Discounting Rate with Anxiety Disorder Symptomatology and Diagnoses

The Psychological record, 2024-03, Vol.74 (1), p.59-74

2024

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of Anxiety-Potentiated Startle After Treatment with Escitalopram or Mindfulness Meditation in Anxiety Disorders

Biological psychiatry (1969), 2024-01, Vol.95 (1), p.85-92

2024

Link zum Volltext

Verfügbarkeit prüfen

Reflections on HIV care and ART – a view from Pietermaritzburg

Southern African journal of HIV medicine, 2014-03, Vol.15 (1), p.16-17

Armstrong, Caroline

2014

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemia Presenting as Acute Appendicitis

Case reports in hematology, 2013-01, Vol.2013, p.815365-4

2013

Link zum Volltext

Verfügbarkeit prüfen

THE TWO NON-BLUE AMUNS OF THE SHRINE OF TAHARQA AT KAWA

Journal of Egyptian archaeology, 2015-01, Vol.101 (1), p.177-195

ARMSTRONG, CAROLINE H.

2015

Link zum Volltext

Verfügbarkeit prüfen

876: M&M CONFERENCE IN A HIGH VOLUME MICU

Critical care medicine, 2014-12, Vol.42, p.A1571

2014

Link zum Volltext

Verfügbarkeit prüfen

1071: CLASSIFICATION OF SEP-1 FAILURE TYPE AND PATIENT OUTCOME

Critical care medicine, 2016-12, Vol.44 (12 Suppl 1), p.344-344

2016

Link zum Volltext

Verfügbarkeit prüfen

NCOG-28. LEEDS LOW GRADE GLIOMA SERVICE 2010-2022: A 12-YEAR EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii203-vii203

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making

Artificial intelligence, 2023-03, Vol.316, p.103839, Article 103839

2023

Link zum Volltext

Verfügbarkeit prüfen

CORONET; COVID-19 in Oncology evaluatiON Tool: Use of machine learning to inform management of COVID-19 in patients with cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1505-1505

2021

Link zum Volltext

Verfügbarkeit prüfen

AIPAC (Active Immunotherapy PAClitaxel): A randomized, double blind, placebo controlled, multinational phase IIb trial evaluating the efficacy of eftilagimod alpha (a soluble LAG-3 fusion protein) in combination with paclitaxel in hormone receptor positive metastatic breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS1109-TPS1109

2018

Link zum Volltext

Verfügbarkeit prüfen

Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib

Blood advances, 2019-05, Vol.3 (9), p.1450-1459

2019

Link zum Volltext

Verfügbarkeit prüfen

T-DM1 to induce response in central nervous system (CNS) metastases from Her2 +ve metastatic breast cancer (MBC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.582-582

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1018-1018

2021

Link zum Volltext

Verfügbarkeit prüfen

EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (g BRCA m) receiving olaparib vs chemotherapy treatment of physician’s choice (TPC) in OlympiAD

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1045-1045

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of the oncolytic peptide LTX-315 combined with checkpoint inhibition generates de novo T-cell responses and clinical benefit in patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3094-3094

2018

Link zum Volltext

Verfügbarkeit prüfen

Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1052-1052

2018

Link zum Volltext

Verfügbarkeit prüfen

RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1059-1059

2017

Link zum Volltext

Verfügbarkeit prüfen

Eribulin for advanced breast cancer: Clinical experience in the real world

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12003-e12003

2014

Link zum Volltext

Verfügbarkeit prüfen

Advancing Psychosocial Treatment for Body Dysmorphic Disorder (BDD): A state-of-the-science review

Behavior therapy

Link zum Volltext

Verfügbarkeit prüfen

Engineering Education for Social Justice: Critical Explorations and Opportunities

Lucena, Juan

1, 2013

Link zum Volltext

Verfügbarkeit prüfen

Idiotypic vaccines for the treatment of B cell lymphoma

Armstrong, Anne Caroline

2002

Link zum Volltext
ProQuest

A study of procedures in opportunity B rooms in socializing maladjusted pupils

Armstrong, Caroline

1931

Link zum Volltext
ProQuest

Longitudinal Relations Among Language Skills, Anger Expression, and Regulatory Strategies in Early Childhood

Child development, 2013-05, Vol.84 (3), p.891-905

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(306)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(213)
Life Sciences & Biomedicine
(196)
Humans
(158)
Female
(79)
Male
(69)
Adult
(46)
Middle Aged
(35)
Social Sciences
(32)
Child
(29)
Aged
(25)
Infant
(25)
Adolescent
(23)
Biological And Medical Sciences
(22)
General & Internal Medicine
(22)
Medicine, General & Internal
(22)
Public, Environmental & Occupational Health
(22)
Child, Preschool
(21)
Children
(21)
Animals
(20)
Patients
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Associations of Delay Discounting Rate with Anxiety Disorder Symptomatology and Diagnoses

Attenuation of Anxiety-Potentiated Startle After Treatment with Escitalopram or Mindfulness Meditation in Anxiety Disorders

Reflections on HIV care and ART – a view from Pietermaritzburg

Acute Myeloid Leukemia Presenting as Acute Appendicitis

THE TWO NON-BLUE AMUNS OF THE SHRINE OF TAHARQA AT KAWA

876: M&M CONFERENCE IN A HIGH VOLUME MICU

1071: CLASSIFICATION OF SEP-1 FAILURE TYPE AND PATIENT OUTCOME

NCOG-28. LEEDS LOW GRADE GLIOMA SERVICE 2010-2022: A 12-YEAR EXPERIENCE

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making

CORONET; COVID-19 in Oncology evaluatiON Tool: Use of machine learning to inform management of COVID-19 in patients with cancer

AIPAC (Active Immunotherapy PAClitaxel): A randomized, double blind, placebo controlled, multinational phase IIb trial evaluating the efficacy of eftilagimod alpha (a soluble LAG-3 fusion protein) in combination with paclitaxel in hormone receptor positive metastatic breast cancer

Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib

T-DM1 to induce response in central nervous system (CNS) metastases from Her2 +ve metastatic breast cancer (MBC)

Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer

EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (g BRCA m) receiving olaparib vs chemotherapy treatment of physician’s choice (TPC) in OlympiAD

A phase I/II study of the oncolytic peptide LTX-315 combined with checkpoint inhibition generates de novo T-cell responses and clinical benefit in patients with advanced solid tumors

Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases

PIPA: A phase Ib study of β-isoform sparing phosphatidylinositol 3-kinase (PI3K) inhibitor taselisib (T) plus palbociclib (P) and fulvestrant (FUL) in PIK3CA -mutant (mt) ER-positive and taselisib (T) plus palbociclib (P) in PIK3CA -mutant (mt) ER-negative advanced breast cancer

RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs)

Eribulin for advanced breast cancer: Clinical experience in the real world

Advancing Psychosocial Treatment for Body Dysmorphic Disorder (BDD): A state-of-the-science review

Engineering Education for Social Justice: Critical Explorations and Opportunities

Idiotypic vaccines for the treatment of B cell lymphoma

A study of procedures in opportunity B rooms in socializing maladjusted pupils

Longitudinal Relations Among Language Skills, Anger Expression, and Regulatory Strategies in Early Childhood

Suchergebnisse filtern